These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10048009

  • 1. [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
    Lachmann C, Jörg KM, Trinkmann R.
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):326-30. PubMed ID: 10048009
    [Abstract] [Full Text] [Related]

  • 2. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID, Baltatzis S, Panagiotidis D, Zafirakis P, Kokolakis SN, Theodossiadis GP.
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [Abstract] [Full Text] [Related]

  • 3. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group.
    Hartenbaum D, Wilson H, Maloney S, Vacarelli L, Orillac R, Sharpe E.
    J Glaucoma; 1999 Aug; 8(4):273-5. PubMed ID: 10464738
    [Abstract] [Full Text] [Related]

  • 4. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M, Yücel I, Akar Y.
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [Abstract] [Full Text] [Related]

  • 5. [Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma].
    Sesar A, Petric I, Sesar I, Lacmnovic-Loncar V, Jurisić D, Tomić Z, Mandić Z.
    Acta Med Croatica; 2006 Sep; 60(2):109-12. PubMed ID: 16848199
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [Abstract] [Full Text] [Related]

  • 7. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE.
    Vestn Oftalmol; 1996 Dec; 112(2):3-4. PubMed ID: 9045485
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Additive effect of dorzolamide hydrochloride to patients taking travoprost: a retrospective study.
    Boyer S, Gay D.
    Optometry; 2008 Sep; 79(9):501-4. PubMed ID: 18722961
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery.
    Zohdy GA, Rogers ZA, Lukaris A, Sells M, Roberts-Harry TJ.
    J R Coll Surg Edinb; 1998 Oct; 43(5):344-6. PubMed ID: 9803110
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.